Resources

Sharing knowledge about promising practices and their sustainable implementation is vital to ending the opioid crisis. Our resources include the recommendations of experts and the perspectives of those on the frontlines.

COVID-19

FORE Opinion Letter: Prescribing Buprenorphine During a Public Health Emergency

April 1, 2020

Legal analysis of four hypothetical scenarios for prescribing buprenorphine for opioid use disorder in the United States during the novel coronavirus outbreak.

arrow-icn

COVID-19

Harvard Law, Bill of Health: Protecting the Vulnerable SUD Population During COVID-19

March 26, 2020

Details concerning the additional challenges faced by the SUD (and OUD) population at this time, the positive ameliorative steps taken by federal, state, and local governments, and recommended additional steps that are needed.

arrow-icn

COVID-19

Webinar: Federal and State Policy Levers to Maintain Access to MOUD During the COVID-19 Pandemic

March 26, 2020

Join Jocelyn Guyer, MPA, and Jodi Manz, MSW, as they review emerging federal and state actions and opportunities (including case studies) to assist those with OUD through the COVID-19 pandemic.
—————————————————————
Recorded Webinar | Slides | Q&A

arrow-icn

COVID-19

SAMHSA: COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance

March 19, 2020

The Substance Abuse and Mental Health Services Administration (SAMHSA) is providing guidance to ensure that SUD treatment services are uninterrupted during the COVID-19 public health emergency.

arrow-icn

COVID-19

Webinar: MOUD and the COVID-19 National Emergency Response

March 19, 2020

Join Dr. Hannah Snyder, Jodi Manz, MSW, and Daniel McClughen, Esq. as they review key steps, fast evolving regulatory changes, and newly issued guidance around MOUD during the COVID-19 pandemic.
—————————————————————
Recorded Webinar | Slides | Q&A

arrow-icn

COVID-19

SAMHSA: FAQ on the provision of methadone and buprenorphine for the treatment of OUD in the COVID-19 Emergency

March 19, 2020

The Substance Abuse and Mental Health Services Administration (SAMHSA) has compiled an FAQ on prescribing MOUD during the COVID-19 pandemic.

arrow-icn